Home ALung Technologies

ALung Technologies

ALung Technologies Reports FDA Granted the Company Emergency Use Authorization Designation to the Hemolung® Respiratory Assist System for RX of COVID-19

Hemolung® RAS is currently being used in the FDA approved VENT-AVOID trial for the study of ECCO2R in the treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AE-COPD).

ALung Announces Significant Progress in its Hemolung Clinical Trial Programs

12/10/18: Achieves major milestones in its clinical trial programs. In the USA, nearly 30 hospitals are online for ALung’s VENT-AVOID Trial of the Hemolung Respiratory Assist System.

ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS

Submission of our IDE is a significant milestone, made possible only through the hard work of our...